D.Western Therapeutics Institute
4576.TTSE GROWTHPharmaceutical
Financials · Standalone
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥388m | ¥470m | ¥428m | ¥412m | ¥412m | ¥335m |
| Operating income | −¥567m | −¥1.2bn | −¥735m | −¥255m | −¥57m | — |
| Ordinary income | −¥571m | −¥1.2bn | −¥729m | −¥241m | −¥39m | −¥201m |
| Total assets | ¥2.1bn | ¥1.6bn | ¥2.4bn | ¥3.0bn | ¥2.4bn | ¥2.8bn |
| Net assets / equity | ¥1.4bn | ¥686m | ¥1.3bn | ¥1.9bn | ¥2.0bn | ¥2.2bn |
| EPS (basic) | ¥-12.99 | ¥-38.15 | ¥-26.85 | ¥-13.05 | ¥-8.21 | ¥-7.43 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 67 figures · EDINET |
| 2025-01-01 → 2025-12-31 | Annual | 181 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 67 figures · EDINET |
| 2024-01-01 → 2024-12-31 | Annual | 181 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 67 figures · EDINET |
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 43 figures · EDINET |
| 2023-01-01 → 2023-12-31 | Annual | 183 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 45 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 69 figures · EDINET |
| 2023-01-01 → 2023-03-31 | Quarterly Q1 | 43 figures · EDINET |
| 2022-01-01 → 2022-12-31 | Annual | 182 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 45 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 69 figures · EDINET |
22 more reports are still being processed.